Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 3/20 | 0.38 |
| ▸ | FDPS | P14324 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | FNTA | P49354 | 2/20 | 0.36 |
| ▸ | FNTB | P49356 | 2/20 | 0.36 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.34 |
| ▸ | LAP3 | P28838 | 1/20 | 0.33 |
| ▸ | MVD | P53602 | 2/20 | 0.33 |
| ▸ | METAP1 | P53582 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL497286 | 0.86 | LAP3 (0.39) | FDPSSMPD1LAP3METAP1 | |
| SCHEMBL2185946 | 0.84 | LAP3 (0.37) | FDPSSMPD1LAP3METAP1 | |
| SCHEMBL29790857 | 0.83 | METAP1 (0.42) | BTN3A1FDPSBLMTDP1SMPD1 | |
| SCHEMBL485995 | 0.81 | — | — | |
| SCHEMBL10879523 | 0.81 | BTN3A1 (0.37) | BTN3A1FDPSBLMTDP1FNTA | |
| SCHEMBL19291560 | 0.81 | FDPS (0.36) | FDPSBLMTDP1FNTAFNTB | |
| SCHEMBL29790872 | 0.80 | SMPD1 (0.46) | FDPSSMPD1LAP3METAP1 | |
| SCHEMBL17151400 | 0.80 | LAP3 (0.33) | LAP3METAP1 | |
| SCHEMBL13557334 | 0.80 | MMP1 (0.38) | FDPSSMPD1LAP3METAP1 | |
| SCHEMBL11410937 | 0.80 | CTSA (0.37) | FDPSTDP1SMPD1LAP3METAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106554933-A | Isoprene gene engineering produces bacterium and its application | 中国科学院上海生命科学研究院 | 2017-04-05 | — | — | CN | claimed |
| US-9453244-B2 | Method for producing a monoalkene by enzymatic conversion of an alkyl monoester | GLOBAL BIOENERGIES (FR) | 2016-09-27 | — | — | US | claimed |
| US-20150159177-A1 | METHOD FOR PRODUCING A MONOALKENE BY ENZYMATIC CONVERSION OF AN ALKYL MONOESTER | GLOBAL BIOENERGIES (FR) | 2015-06-11 | — | — | US | claimed |
| EP-2867365-A1 | PROCESS FOR PRODUCING A C2-C10 MONOALKENE EMPLOYING A TERPENE SYNTHASE OR A PRENYL TRANSFERASE | Scientist of Fortune S.A. (LU) | 2015-05-06 | — | — | EP | claimed |
| WO-2014001517-A1 | PROCESS FOR PRODUCING A C2-C10 MONOALKENE EMPLOYING A TERPENE SYNTHASE OR A PRENYL TRANSFERASE | SCIENTIST OF FORTUNE S.A. (LU) | 2014-01-03 | — | — | WO | claimed |
| EP-4277731-A1 | MEMBRANE FOR WATER FILTRATION | Aquaporin A/S (DK) | 2023-11-22 | — | — | EP | disclosed |
| CN-116745025-A | membrane for water filtration | 水通道蛋白有限公司 | 2023-09-12 | — | — | CN | disclosed |
| WO-2022152748-A1 | MEMBRANE FOR WATER FILTRATION | AQUAPORIN A/S (DK) | 2022-07-21 | — | — | WO | disclosed |
| CN-106554933-A | Isoprene gene engineering produces bacterium and its application | 中国科学院上海生命科学研究院 | 2017-04-05 | — | — | CN | disclosed |
| US-9453244-B2 | Method for producing a monoalkene by enzymatic conversion of an alkyl monoester | GLOBAL BIOENERGIES (FR) | 2016-09-27 | — | — | US | disclosed |
| US-20150159177-A1 | METHOD FOR PRODUCING A MONOALKENE BY ENZYMATIC CONVERSION OF AN ALKYL MONOESTER | GLOBAL BIOENERGIES (FR) | 2015-06-11 | — | — | US | disclosed |
| EP-2867365-A1 | PROCESS FOR PRODUCING A C2-C10 MONOALKENE EMPLOYING A TERPENE SYNTHASE OR A PRENYL TRANSFERASE | Scientist of Fortune S.A. (LU) | 2015-05-06 | — | — | EP | disclosed |
| WO-2014001517-A1 | PROCESS FOR PRODUCING A C2-C10 MONOALKENE EMPLOYING A TERPENE SYNTHASE OR A PRENYL TRANSFERASE | SCIENTIST OF FORTUNE S.A. (LU) | 2014-01-03 | — | — | WO | disclosed |
| US-7858661-B2 | Protein refolding agent and refolding method | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2010-12-28 | — | — | US | disclosed |
| US-20100168403-A1 | Protein refolding agent and refolding method | YAMAGUCHI SHUNICHLRO | 2010-07-01 | — | — | US | disclosed |
| US-20090111971-A1 | PROTEIN REFOLDING AGENT AND REFOLDING METHOD | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2009-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090111971-A1 | PROTEIN REFOLDING AGENT AND REFOLDING METHOD | HSPA5, HSPBP1, RRBP1 | BTN3A1 2857/4885FDPS 532/4885BLM 3232/4885 |
| US-20100168403-A1 | Protein refolding agent and refolding method | HSPA5, HSPBP1, RRBP1 | BTN3A1 2931/4885FDPS 566/4885BLM 3143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.